Skip to menu
COMPANY
OVERVIEW AND HISTORY
PEOPLE
TECHNOLOGY
VESSEL NORMALIZATION
EAGLES™ PLATFORM
PIPELINE
Pipeline Overview
MT-101
MT-103
MT-201
COMMUNICATION
MabTics NEWS
RECRUIT
CONTACT
NOTICE
Q&A
COMPANY
- OVERVIEW AND HISTORY
- PEOPLE
TECHNOLOGY
- VESSEL NORMALIZATION
- EAGLES™ PLATFORM
PIPELINE
- Pipeline Overview
- MT-101
- MT-103
- MT-201
COMMUNICATION
- MabTics NEWS
- RECRUIT
CONTACT
- NOTICE
- Q&A
PIPELINE
PIPELINE
COMPANY
TECHNOLOGY
PIPELINE
COMMUNICATION
CONTACT
MT-103
Pipeline Overview
MT-101
MT-103
MT-201
MabTics
MT-103
A bispecific antibody to activate Tie2 and antagonize VEGF for wAMD
01
MT-103 overview
02
Age-related Macular Degeneration (wAMD)
03
Diabetic Retinopathy (DR) & Diabetic Macular Edema (DME)